NDC 76282-709
Lanreotide Acetate
Lanreotide Acetate
Lanreotide Acetate is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Exelan Pharmaceuticals, Inc.. The primary component is Lanreotide Acetate.
| Product ID | 76282-709_1eaf1cf6-23b6-4c54-8cbf-a96d1f74c4cc |
| NDC | 76282-709 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lanreotide Acetate |
| Generic Name | Lanreotide Acetate |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-06-01 |
| Marketing Category | NDA / |
| Application Number | NDA215395 |
| Labeler Name | Exelan Pharmaceuticals, Inc. |
| Substance Name | LANREOTIDE ACETATE |
| Active Ingredient Strength | 60 mg/.2mL |
| Pharm Classes | Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |